tradingkey.logo

Agilent Technologies Inc

A

127.449USD

-1.301-1.01%
Market hours ETQuotes delayed by 15 min
36.14BMarket Cap
29.63P/E TTM

Agilent Technologies Inc

127.449

-1.301-1.01%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-05

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
16 / 280
Overall Ranking
71 / 4731
Industry
Healthcare Services & Equipment

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 20 analysts
Buy
Current Rating
134.036
Target Price
+4.11%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.26%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 21.26%.
Fairly Valued
The company’s latest is 31.59, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 262.65M shares, decreasing 1.37% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 33.87M shares of this stock.

Financial Health

Currency: USD Updated2025-09-05

The company's current financial score is 7.57, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 1.67B, representing a year-over-year increase of 6.04%, while its net profit experienced a year-over-year increase of 30.19%.

Score

Industry at a Glance

Previous score
7.57
Change
0

Financials

8.48

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

7.46

Operational Efficiency

7.22

Growth Potential

7.14

Shareholder Returns

7.53

Company Valuation

Currency: USD Updated2025-09-05

The company’s current valuation score is 4.80, which is higher than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 29.12, which is 14.22% below the recent high of 33.26 and -0.64% above the recent low of 29.30.

Score

Industry at a Glance

Previous score
4.80
Change
0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 16/280
No Data

Earnings Forecast

Currency: USD Updated2025-09-05

The company’s current earnings forecast score is 7.30, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Agilent Technologies Inc is 130.00, with a high of 150.00 and a low of 120.00.

Score

Industry at a Glance

Previous score
7.30
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 20 analysts
Buy
Current Rating
134.036
Target Price
+4.11%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Agilent Technologies Inc
A
20
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-05

The company’s current price momentum score is 8.61, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 123.67 and the support level at 112.45, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.30
Change
-0.12

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(1)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
1.999
Buy
RSI(14)
67.958
Neutral
STOCH(KDJ)(9,3,3)
87.398
Overbought
ATR(14)
3.061
High Vlolatility
CCI(14)
155.863
Buy
Williams %R
16.106
Overbought
TRIX(12,20)
0.282
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
126.664
Buy
MA10
123.605
Buy
MA20
120.750
Buy
MA50
119.016
Buy
MA100
115.095
Buy
MA200
123.803
Buy

Institutional Confidence

Currency: USD Updated2025-09-05

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 92.46%, representing a quarter-over-quarter decrease of 0.09%. The largest institutional shareholder is The Vanguard, holding a total of 33.87M shares, representing 11.92% of shares outstanding, with 2.91% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
33.28M
+0.73%
BlackRock Institutional Trust Company, N.A.
15.37M
+0.25%
State Street Global Advisors (US)
12.61M
-0.82%
MFS Investment Management
10.98M
-4.46%
Wellington Management Company, LLP
8.93M
-4.04%
T. Rowe Price Investment Management, Inc.
7.60M
-7.65%
Geode Capital Management, L.L.C.
7.20M
+2.88%
Generation Investment Management LLP
Star Investors
4.98M
+19.82%
Pictet Asset Management Ltd.
5.34M
+2.46%
State Farm Insurance Companies
4.52M
--
1
2

Risk Assessment

Currency: USD Updated2025-09-05

The company's beta value is 1.24. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
4.86
Change
0
Beta vs S&P 500 index
1.26
VaR
+2.89%
240-Day Maximum Drawdown
+34.93%
240-Day Volatility
+33.17%
Return
Best Daily Return
60 days
+5.28%
120 days
+8.06%
5 years
+8.72%
Worst Daily Return
60 days
-5.95%
120 days
-6.63%
5 years
-9.66%
Sharpe Ratio
60 days
+1.50
120 days
+0.73
5 years
+0.27
Risk Assessment
Maximum Drawdown
240 days
+34.93%
3 years
+37.58%
5 years
+44.62%
Return-to-Drawdown Ratio
240 days
-0.27
3 years
+0.02
5 years
+0.07
Skewness
240 days
+0.23
3 years
+0.12
5 years
+0.07
Volatility
Realised Volatility
240 days
+33.17%
5 years
+30.56%
Standardised True Range
240 days
+2.66%
5 years
+2.55%
Downside Risk-Adjusted Return
120 days
+106.55%
240 days
+106.55%
Maximum Daily Upside Volatility
60 days
+23.52%
Maximum Daily Downside Volatility
60 days
+19.92%
Liquidity
Average Turnover Rate
60 days
+0.60%
120 days
+0.71%
5 years
--
Turnover Deviation
20 days
-22.45%
60 days
-5.23%
120 days
+10.69%

Peer Comparison

Currency: USD Updated2025-09-05
Agilent Technologies Inc
Agilent Technologies Inc
A
7.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
Merit Medical Systems Inc
MMSI
7.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
Tenet Healthcare Corp
THC
7.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
Brightspring Health Services Inc
BTSG
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
7.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.

KeyAI